Immetas

Recent Finacing

Series A

Recent Raise

$11M

Immetas Therapeutics discovers and develops biologic and small‑molecule therapeutics that modulate the innate immune system, engineering bispecific antibodies to regulate tumor‑microenvironment inflammation and address checkpoint resistance.